Small Scale Peptide and Impurity Isolation Using the ACQUITY UPLC H-Class and Waters Fraction Manager-Analytical Systems

Significance of the Topic

Peptide-based molecules are gaining traction in pharmaceutical research due to their high specificity and potency. Rapid isolation and characterization of both target peptides and their closely eluting impurities is critical for accelerating process development, improving yield, and ensuring product quality.

Objectives and Overview of the Study

This work demonstrates the utility of the ACQUITY UPLC H-Class System coupled with the Waters Fraction Manager-Analytical (WFM-A) for small-scale isolation of a synthetic 16-residue peptide and two closely related impurities. The study illustrates how geometric scaling, focused gradients, and low dispersion fraction collection enable efficient purification from crude samples.

Methodology and Instrumentation

The crude peptide (56% purity, 2.4 mg) was dissolved in DMSO and filtered before injection. Geometric scaling of an optimized gradient (28–36% B) from a 4.6×100 mm to a 4.6×50 mm XBridge Peptide BEH C18 column halved both the gradient time (18 to 9 min) and injection volume (10 to 5 µL). A shallow focused gradient (28–32% B in 5 min) with a slope of 0.2–0.3% per column volume improved impurity resolution.

Used Instrumentation

• ACQUITY UPLC H-Class System with quaternary solvent manager
• ACQUITY UPLC PDA Detector
• Waters Fraction Manager-Analytical (WFM-A)
• Empower 3 software for data acquisition and fraction scheduling
• XBridge Peptide BEH C18 columns (4.6×50 and 4.6×100 mm, 5 µm)
• 0.45 µm GHP Acrodisc syringe filters

Results and Discussion

Five replicate injections on the 4.6×50 mm column overlaid with excellent retention time precision, confirming system reproducibility. Comparison with a traditional collector highlighted the WFM-A’s low dispersion valve design, which preserved narrow peak shapes for high-recovery collection. Three target fractions (impurity 1, peptide, impurity 2) were isolated in ten injections; individual fraction volumes were highly consistent (0.29–0.55 mL). Post-collection analysis using both fast (3.38%/column volume) and shallow (0.30%/column volume) gradients showed: impurity 1 purity 83% (fast) vs. 77% (focused), peptide 100% in both, and impurity 2 purity 98% (fast) vs. 80% (focused). The deeper gradient resolved additional coeluting species.

Practical Benefits and Applications

• Small sample requirements and minimal solvent consumption reduce cost and waste.
• Fast valve switching and low dispersion fraction collection enhance peak recovery.
• Focused gradients accelerate method development and improve impurity resolution.
• The configuration is adaptable to synthetic, metabolic, or natural product mixtures.

Future Trends and Potential Applications

Advancements in fraction collector design and integration with automated workflows will further streamline small-scale isolations. Implementation of AI-driven gradient optimization and real-time impurity profiling can enhance purification efficiency. The approach is extensible to complex biological extracts and metabolite studies where sample quantities are limited.

Conclusion

The ACQUITY UPLC H-Class System with WFM-A enables rapid, reproducible small-scale peptide purification with high recovery and resolution. Geometric scaling and focused gradients facilitate efficient isolation of target peptides and closely eluting impurities, supporting accelerated peptide process development.

References

1. Uhlig T, Kyprianou T, Martinelli FG, Oppici CA, Heiligers D, Hills D, Calvo XR, Verhaert P. The emergence of peptides in the pharmaceutical business: From exploration to exploitation. EuPA Open Proteomics 4 (2014) 58–69.
2. Aubin A, Jablonski J. Prep 150 LC System: Considerations for Analytical to Preparative Scaling. Waters Application Note 720005458EN. July 2015.
3. Jablonski J, Aubin A. Peptide Isolation Using the Prep 150 LC System. Waters Application Note 720005455EN. July 2015.
4. Jablonski J, Wheat T, Diehl D. Developing Focused Gradients for Isolation and Purification. Waters Technical Note 720002955EN. September 2009.
5. Optimized System Dispersion for UPLC Performance in a Versatile LC Design. Waters Technology Brief 720003651EN. July 2010.
6. Exact Control of Solvent Composition with the ACQUITY UPLC H-Class Quaternary Solvent Manager. Waters Technology Brief 720004405EN. July 2012.
7. Delivering Repeatable, Linear, and Accurate Injection Volumes for UPLC and HPLC. Waters Technology Brief 720003445EN. April 2010.